Key facts
- Accretion Pharmaceuticals’s last known valuation is $13.2M (May 2025).
- It has raised $3.7M; the latest was IPO ($3.5M) in May 2025.
- Status: In IPO Registration.
- ·Watchlist + deal alerts for Accretion Pharmaceuticals
- ·The full record, as it builds
Funding rounds
No funding rounds for Accretion Pharmaceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Accretion Pharmaceuticals
Accretion Pharmaceuticals Ltd is engaged in the manufacturing of Medicinal & Pharmaceutical Products. The company manufactures tablets, oral liquid, capsule, cream, ointment, mouthwash, dusting powder, gel, ear drops, lotion, shampoo, powder, syrup, among others.
- Sector
- Healthcare
- HQ
- Ahmedabad, India
- Founded
- 2012
- Employees
- 200
- Website
- accretionpharma.com/
- Ownership
- In IPO Registration
Accretion Pharmaceuticals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Accretion Pharmaceuticals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Accretion Pharmaceuticals in its N-PORT filings yet. We sweep new filings monthly.